Moffitt Cancer Center - Site 102 — Tampa, Florida

Moffitt Cancer Center - Site 102 is a clinical research site located in Tampa, Florida, United States 33612.

Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.

Moffitt Cancer Center - Site 102 has participated in 1 clinical trials.

Therapeutic areas: Solid Tumor.

Sponsors: Kadmon, a Sanofi Company.

Sponsor Feasibility Report

Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Moffitt Cancer Center - Site 102?

Moffitt Cancer Center - Site 102 has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Moffitt Cancer Center - Site 102 conducted?

Moffitt Cancer Center - Site 102 has 1 clinical trials on record. Their work covers Solid Tumor.

Is Moffitt Cancer Center - Site 102 accredited by Crixeo Health?

Moffitt Cancer Center - Site 102 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Moffitt Cancer Center - Site 102?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.